N/A
N=32
Effects of Photobiomodulation on Postoperative Pain After Primary Endodontic Therapy in Molars With Symptomatic Apical Periodontitis
Postoperative Pain
Bottom Line
View on ClinicalTrials.gov: NCT05032612 ↗Enrolled (actual)
32
Serious AEs
0.0%
Results posted
Mar 2023
Primary outcome: Primary: Pain as Assessed by the Visual Analog Scale — 0; .33 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- PBM Therapy (Device); PBM Sham (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- The University of Texas Health Science Center, Houston
- Primary completion
- Mar 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain as Assessed by the Visual Analog Scale |
3.94; 6.13; 1.94; 3.86; 0.76; 3.33 | — |
| SECONDARY Pain as Assessed by the Visual Analog Scale |
3.94; 6.13; 1.94; 3.86; 0.76; 3.33 | — |
Summary
The purpose of this study is to evaluate the effects of photobiomodulation (PBM) on postoperative pain after endodontic treatment in mandibular molar teeth diagnosed with symptomatic apical periodontitis.
Eligibility Criteria
Inclusion Criteria
- Posterior mandibular molars
- No previous root canal therapy on the tooth in question
- Able to complete the endodontic treatment in one visit
Exclusion Criteria
- Maxillary teeth, mandibular anteriors and premolars
- Infection (swelling, sinus tract) on the tooth in question
- Periodontal disease on the tooth in question
- Dental trauma
- Crown/ root fractures
- Systemic diseases
- Immunocompromised patients
Data sourced from ClinicalTrials.gov (NCT05032612). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.